Angela Marie Feraco, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Professional-Family Relations | 4 | 2020 | 501 | 0.870 |
Why?
|
Palliative Care | 6 | 2022 | 3644 | 0.800 |
Why?
|
Parents | 5 | 2022 | 3596 | 0.800 |
Why?
|
Communication | 8 | 2024 | 3910 | 0.790 |
Why?
|
Neoplasms | 11 | 2023 | 22386 | 0.650 |
Why?
|
Pediatrics | 6 | 2024 | 3622 | 0.580 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2023 | 1376 | 0.520 |
Why?
|
Hodgkin Disease | 1 | 2023 | 1386 | 0.510 |
Why?
|
Home Care Services | 1 | 2021 | 655 | 0.490 |
Why?
|
Interdisciplinary Communication | 1 | 2020 | 937 | 0.480 |
Why?
|
Language | 2 | 2022 | 1557 | 0.450 |
Why?
|
Lymphoma | 1 | 2023 | 1907 | 0.450 |
Why?
|
Access to Information | 1 | 2017 | 317 | 0.440 |
Why?
|
Truth Disclosure | 1 | 2017 | 433 | 0.410 |
Why?
|
Child Welfare | 1 | 2017 | 523 | 0.410 |
Why?
|
Parent-Child Relations | 1 | 2017 | 775 | 0.390 |
Why?
|
Terminal Care | 1 | 2021 | 1773 | 0.330 |
Why?
|
Internship and Residency | 6 | 2018 | 5952 | 0.330 |
Why?
|
Physician-Patient Relations | 3 | 2024 | 3267 | 0.310 |
Why?
|
Medical Oncology | 2 | 2018 | 2347 | 0.290 |
Why?
|
Decision Making | 2 | 2019 | 3961 | 0.280 |
Why?
|
Medical Errors | 3 | 2017 | 1263 | 0.260 |
Why?
|
Child | 15 | 2024 | 80863 | 0.230 |
Why?
|
Education, Medical | 1 | 2016 | 1742 | 0.220 |
Why?
|
Switzerland | 1 | 2023 | 322 | 0.200 |
Why?
|
Medical Records, Problem-Oriented | 1 | 2012 | 36 | 0.200 |
Why?
|
Verbal Behavior | 1 | 2012 | 336 | 0.180 |
Why?
|
Hospitals, Pediatric | 2 | 2021 | 1876 | 0.170 |
Why?
|
Quality of Life | 2 | 2022 | 13497 | 0.160 |
Why?
|
Communication Barriers | 1 | 2022 | 419 | 0.160 |
Why?
|
Immunophenotyping | 1 | 2024 | 1869 | 0.160 |
Why?
|
Burnout, Professional | 2 | 2018 | 712 | 0.160 |
Why?
|
Family | 2 | 2020 | 3208 | 0.160 |
Why?
|
Reminder Systems | 1 | 2012 | 386 | 0.160 |
Why?
|
Congresses as Topic | 1 | 2023 | 810 | 0.150 |
Why?
|
Interview, Psychological | 1 | 2020 | 812 | 0.140 |
Why?
|
Dissent and Disputes | 1 | 2017 | 150 | 0.130 |
Why?
|
Spouses | 1 | 2018 | 286 | 0.130 |
Why?
|
Health Communication | 1 | 2019 | 216 | 0.130 |
Why?
|
Child, Preschool | 7 | 2022 | 42623 | 0.130 |
Why?
|
Employee Performance Appraisal | 1 | 2016 | 86 | 0.130 |
Why?
|
Teaching Materials | 1 | 2016 | 85 | 0.130 |
Why?
|
Gene Fusion | 1 | 2018 | 356 | 0.120 |
Why?
|
Humans | 26 | 2024 | 768451 | 0.120 |
Why?
|
Continuity of Patient Care | 1 | 2012 | 1076 | 0.120 |
Why?
|
Job Satisfaction | 1 | 2018 | 549 | 0.120 |
Why?
|
Competency-Based Education | 1 | 2016 | 224 | 0.110 |
Why?
|
Personal Satisfaction | 1 | 2018 | 648 | 0.110 |
Why?
|
Perception | 1 | 2020 | 1207 | 0.110 |
Why?
|
Information Dissemination | 1 | 2012 | 1138 | 0.110 |
Why?
|
Cardiology | 1 | 2024 | 1701 | 0.110 |
Why?
|
Memory | 1 | 2012 | 2210 | 0.100 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2024 | 2331 | 0.090 |
Why?
|
Pilot Projects | 2 | 2024 | 8730 | 0.090 |
Why?
|
Interpersonal Relations | 1 | 2018 | 1439 | 0.090 |
Why?
|
Video Recording | 1 | 2016 | 974 | 0.090 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2018 | 1628 | 0.090 |
Why?
|
Patient Care Team | 1 | 2012 | 2526 | 0.090 |
Why?
|
Young Adult | 5 | 2023 | 60045 | 0.090 |
Why?
|
Feasibility Studies | 1 | 2020 | 5308 | 0.080 |
Why?
|
Infant | 4 | 2020 | 36497 | 0.080 |
Why?
|
Educational Measurement | 1 | 2016 | 1256 | 0.080 |
Why?
|
Immunotherapy | 1 | 2024 | 4728 | 0.080 |
Why?
|
Liver Neoplasms | 1 | 2024 | 4362 | 0.080 |
Why?
|
Pyrazoles | 1 | 2018 | 2024 | 0.070 |
Why?
|
Program Evaluation | 1 | 2016 | 2508 | 0.070 |
Why?
|
Adaptation, Psychological | 1 | 2018 | 2665 | 0.070 |
Why?
|
Qualitative Research | 1 | 2018 | 3115 | 0.070 |
Why?
|
Adolescent | 5 | 2024 | 89168 | 0.070 |
Why?
|
Pyrimidines | 1 | 2018 | 3050 | 0.060 |
Why?
|
Clinical Competence | 2 | 2024 | 4841 | 0.060 |
Why?
|
Cross-Sectional Studies | 4 | 2020 | 26351 | 0.060 |
Why?
|
Quality of Health Care | 1 | 2020 | 4340 | 0.060 |
Why?
|
Anxiety | 1 | 2019 | 4655 | 0.060 |
Why?
|
Organizational Case Studies | 1 | 2014 | 301 | 0.060 |
Why?
|
Male | 11 | 2024 | 364781 | 0.060 |
Why?
|
Boston | 1 | 2016 | 9361 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2017 | 3922 | 0.050 |
Why?
|
Prognosis | 1 | 2023 | 30028 | 0.050 |
Why?
|
Female | 10 | 2024 | 396943 | 0.050 |
Why?
|
Adult | 5 | 2020 | 223542 | 0.050 |
Why?
|
Time Factors | 2 | 2020 | 40271 | 0.050 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 5709 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2016 | 20231 | 0.050 |
Why?
|
Workflow | 1 | 2014 | 861 | 0.040 |
Why?
|
Inservice Training | 1 | 2012 | 377 | 0.040 |
Why?
|
Education, Medical, Graduate | 2 | 2024 | 2411 | 0.040 |
Why?
|
Heart Ventricles | 1 | 2009 | 3839 | 0.040 |
Why?
|
Receptor, trkB | 1 | 2018 | 125 | 0.040 |
Why?
|
Receptor, trkA | 1 | 2018 | 159 | 0.030 |
Why?
|
Guilt | 1 | 2017 | 95 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 2279 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39430 | 0.030 |
Why?
|
Family Relations | 1 | 2018 | 318 | 0.030 |
Why?
|
Fellowships and Scholarships | 1 | 2024 | 1134 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13708 | 0.030 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2018 | 497 | 0.030 |
Why?
|
Informed Consent | 1 | 2021 | 1012 | 0.030 |
Why?
|
Uncertainty | 1 | 2019 | 758 | 0.030 |
Why?
|
New England | 1 | 2017 | 1056 | 0.030 |
Why?
|
Sleep Deprivation | 1 | 2018 | 848 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 2012 | 2179 | 0.020 |
Why?
|
Length of Stay | 1 | 2014 | 6521 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4861 | 0.020 |
Why?
|
Administration, Oral | 1 | 2018 | 4041 | 0.020 |
Why?
|
Prospective Studies | 2 | 2023 | 54914 | 0.020 |
Why?
|
Curriculum | 1 | 2012 | 3778 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 9507 | 0.020 |
Why?
|
Endothelin-1 | 1 | 2009 | 302 | 0.020 |
Why?
|
Aged | 1 | 2020 | 171520 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2018 | 3713 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15965 | 0.020 |
Why?
|
Middle Aged | 1 | 2020 | 223418 | 0.020 |
Why?
|
Heart Failure | 1 | 2009 | 11857 | 0.020 |
Why?
|
Troponin I | 1 | 2009 | 662 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2024 | 65409 | 0.010 |
Why?
|
Patient Discharge | 1 | 2017 | 3471 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2006 | 11206 | 0.010 |
Why?
|
ROC Curve | 1 | 2009 | 3624 | 0.010 |
Why?
|
Age Factors | 1 | 2018 | 18478 | 0.010 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2009 | 1751 | 0.010 |
Why?
|
Mutation | 1 | 2024 | 30243 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2009 | 3854 | 0.010 |
Why?
|
Logistic Models | 1 | 2009 | 13324 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2009 | 14728 | 0.010 |
Why?
|
United States | 1 | 2018 | 73121 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2009 | 26395 | 0.010 |
Why?
|
Risk Factors | 1 | 2006 | 74915 | 0.000 |
Why?
|